Mauriac L - Search Results

1

Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF + tamoxifen in a single centre.

Mauriac L, Durand M, Chauvergne J, Bonichon F, Avril A, Mage P, Dilhuydy MH, Le Treut A, Wafflart J, Marée D, et al. Mauriac L, et al. Breast Cancer Res Treat. 1988 May;11(2):179-86. doi: 10.1007/BF01805842. Breast Cancer Res Treat. 1988. PMID: 3042053 Clinical Trial.

2

[Value of thymidine kinase in the prediction of response to treatment by chemotherapy or hormone therapy in breast cancer].

Bennini N, Mauriac L, Wafflart J, Bonichon F, Durand M. Bennini N, et al. Among authors: mauriac l. Bull Cancer. 1992;79(8):773-9. Bull Cancer. 1992. PMID: 1467600 French.

3

Randomized trial of adjuvant chemotherapy for operable breast cancer comparing i.v. CMF to an epirubicin-containing regimen [see comment].

Mauriac L, Durand M, Chauvergne J, Dilhuydy JM, Bonichon F. Mauriac L, et al. Ann Oncol. 1992 Jun;3(6):439-43. doi: 10.1093/oxfordjournals.annonc.a058231. Ann Oncol. 1992. PMID: 1498061 Clinical Trial.

4

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre.

Mauriac L, Durand M, Avril A, Dilhuydy JM. Mauriac L, et al. Ann Oncol. 1991 May;2(5):347-54. doi: 10.1093/oxfordjournals.annonc.a057953. Ann Oncol. 1991. PMID: 1954179 Free article. Clinical Trial.

5

[Cancers of the breast at metastatic high-risk: prediction of survival by steroidal receptors].

Mauriac L, Durand M, Chauvergne J, David M, Wafflart J. Mauriac L, et al. Bull Cancer. 1989;76(1):33-41. Bull Cancer. 1989. PMID: 2713513 Clinical Trial. French.

6

Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.

Soubeyran I, Quénel N, Mauriac L, Durand M, Bonichon F, Coindre J-M. Soubeyran I, et al. Among authors: mauriac l. Br J Cancer. 1996 Mar;73(6):735-43. doi: 10.1038/bjc.1996.129. Br J Cancer. 1996. PMID: 8611373 Free PMC article.

7

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.

Soubeyran I, Quénel N, Coindre JM, Bonichon F, Durand M, Wafflart J, Mauriac L. Soubeyran I, et al. Among authors: mauriac l. Br J Cancer. 1996 Oct;74(7):1120-5. doi: 10.1038/bjc.1996.500. Br J Cancer. 1996. PMID: 8855985 Free PMC article.

8

[Results of 10 years of a randomized trial of neoadjuvant chemotherapy in breast cancers larger than 3 cm].

Avril A, Faucher A, Bussières E, Stöckle E, Durand M, Mauriac L, Bonichon F, Dilhuydy JM, Campo ML. Avril A, et al. Among authors: mauriac l. Chirurgie. 1998 Jun;123(3):247-56. doi: 10.1016/s0001-4001(98)80116-5. Chirurgie. 1998. PMID: 9752515 Clinical Trial. French.

9

Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.

de Mascarel I, Bonichon F, MacGrogan G, de Lara CT, Avril A, Picot V, Durand M, Mauriac L, Trojani M, Coindre JM. de Mascarel I, et al. Among authors: mauriac l. Breast Cancer Res Treat. 2000 May;61(2):151-9. doi: 10.1023/a:1006437902770. Breast Cancer Res Treat. 2000. PMID: 10942101

10

[Relay chemotherapy using continuous perfusion of cisplatin and fluoro-uracil in advanced cancer of the breast. Analysis of a series of 50 cases].

Chauvergne J, Mauriac L, Durand M, David M, Ravaud A, Bécouarn Y. Chauvergne J, et al. Among authors: mauriac l. Rev Fr Gynecol Obstet. 1990 Apr;85(4):211-9. Rev Fr Gynecol Obstet. 1990. PMID: 2367799 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters